Keywords: sluggish cognitive tempo; attention-deficit/
hyperactivity disorder; methylphenidate; atomoxetine; treatment
Key Clinical Message: Although there is no proven evidence
regarding pharmacotherapy of Sluggish Cognitive Tempo (SCT), we
experienced that atomoxetine had much more effects in decreasing SCT
symptoms compared to methylphenidate in a case with SCT and subthreshold
ADHD.